Eliem Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELYM and other ETFs, options, and stocks.

About ELYM

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

CEO

Andrew D. Levin

CEOAndrew D. Levin

Employees

Employees9

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

2018

Founded2018

Employees

Employees9

ELYM Key Statistics

Market cap

104.22M

Market cap104.22M

Price-Earnings ratio

-2.79

Price-Earnings ratio-2.79

Dividend yield

—

Dividend yield—

Average volume

4.26M

Average volume4.26M

High today

$3.86

High today$3.86

Low today

$3.66

Low today$3.66

Open price

$3.82

Open price$3.82

Volume

113.36K

Volume113.36K

52 Week high

$5.19

52 Week high$5.19

52 Week low

$2.34

52 Week low$2.34

Eliem Therapeutics

Why Robinhood?

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Show more

ELYM Key Statistics

Eliem Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy and other disorders of the peripheral and central nervous systems.